Akyuz E, Polat AK, Eroglu E, Kullu I, Angelopoulou E, Paudel YN. Revisiting the role of neurotransmitters in epilepsy: an updated review. Life Sci. 2021;265: 118826.
Article CAS PubMed Google Scholar
Perucca E, White HS, Bialer M. New GABA-targeting therapies for the treatment of seizures and epilepsy. II. Treatments in clinical development. CNS Drugs. https://doi.org/10.1007/s40263-023-01025-4.
Bergmann KJ. Progabide: a new GABA-mimetic agent in clinical use. Clin Neuropharmacol. 1985;8:13–26.
Article CAS PubMed Google Scholar
Grant SM, Heel RC. Vigabatrin: a r review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs. 1991;41:889–926.
Article CAS PubMed Google Scholar
Schachter SC. A review of the antiepileptic drug tiagabine. Clin Neuropharmacol. 1999;22:312–7.
Löscher W. Single-target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of epilepsy. Front Pharmacol. 2021;12: 730257.
Article PubMed PubMed Central Google Scholar
Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42(Suppl. 3):8–12.
Liu YQ, Yu F, Liu WH, He XH, Peng BW. Dysfunction of hippocampal interneurons in epilepsy. Neurosci Bull. 2014;30:985–98.
Article CAS PubMed PubMed Central Google Scholar
Sarlo GL, Holton KF. Brain concentrations of glutamate and GABA in human epilepsy: a review. Seizure. 2021;91:213–27.
Nohria V, Giller E. Ganaxolone. Neurotherapeutics. 2007;4:102–5.
Article CAS PubMed PubMed Central Google Scholar
White HS, Rho JM, editors. Mechanisms of action of antiepileptic drugs. New York: Professional Communications, Inc.; 2010.
Squires RF, Saederup E, Crawley JN, Skolnick P, Paul SM. Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci. 1984;35:1439–44.
Article CAS PubMed Google Scholar
Newland CF, Cull-Candy SG. On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat. J Physiol. 1992;447:191–213.
Article CAS PubMed PubMed Central Google Scholar
Absalom NL, Liao VWY, Johannesen KMH, Gardella E, Jacobs J, Lesca G, et al. Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies. Nat Commun. 2022;13:1822.
Article CAS PubMed PubMed Central Google Scholar
Chuang SH, Reddy DS. Genetic and molecular regulation of extrasynaptic GABA-A receptors in the brain: therapeutic insights for epilepsy. J Pharmacol Exp Ther. 2018;364:180–97.
Article CAS PubMed PubMed Central Google Scholar
Feng Y, Wei ZH, Liu C, Li GY, Qiao XZ, Gan YJ, et al. Genetic variations in GABA metabolism and epilepsy. Seizure. 2022;101:22–9.
Cossette P, Lachance-Touchette P, Rouleau GA. Mutated GABAA receptor subunits in idiopathic generalized epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper’s basic mechanisms of the epilepsies. 4th ed. Bethesda (MD): National Center for Biotechnology Information (US); 2012: p. 827–46.
Hernandez CC, Tian X, Hu N, Shen W, Catron MA, Yang Y, et al. Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABAA receptors. Brain Commun. 2021;3:fcab033.
Article PubMed PubMed Central Google Scholar
Kang J-Q. Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies. Epilepsy Res. 2017;137:9–18.
Article CAS PubMed PubMed Central Google Scholar
Macdonald RL, Kang JQ, Gallagher MJ. GABAA receptor subunit mutations and genetic epilepsies. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's basic mechanisms of the epilepsies. 4th ed. Bethesda (MD): National Center for Biotechnology Information (US); 2012: p. 857–68.
Maillard PY, Baer S, Schaefer É, Desnous B, Villeneuve N, Lépine A, et al. Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): a cohort study, review of literature, and genotype-phenotype correlation. Epilepsia. 2022;63:2519–33.
Article CAS PubMed PubMed Central Google Scholar
Riaz M, Abbasi MH, Sheikh N, Saleem T, Virk AO. GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients. Seizure. 2021;93:88–94.
Symonds JD, Zuberi SM, Johnson MR. Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment. Curr Opin Neurol. 2017;30:193–9.
Iadarola MJ, Gale K. Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science. 1982;218:1237–40.
Article CAS PubMed Google Scholar
Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J Clin Neurophysiol. 1992;9:264–77.
Article CAS PubMed Google Scholar
Snodgrass SR. GABA and epilepsy: their complex relationship and the evolution of our understanding. J Child Neurol. 1992;7:77–86.
Article CAS PubMed Google Scholar
Hosford DA, Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia. 1997;38:408–14.
Article CAS PubMed Google Scholar
Berkovic SF. Aggravation of generalized epilepsies. Epilepsia. 1998;39(Suppl. 3):S11–4.
Article CAS PubMed Google Scholar
Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther. 2006;319:790–8.
Article CAS PubMed Google Scholar
Zheng T, Clarke AL, Morris MJ, Reid CA, Petrou S, O’Brien TJ. Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures. Epilepsia. 2009;50:83–7.
Article CAS PubMed Google Scholar
Hosford DA, Clark S, Cao Z, Wilson WA Jr, Lin FH, Morrisett RA, et al. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science. 1992;257:398–401.
Article CAS PubMed Google Scholar
Motalli R, Louvel J, Tancredi V, Kurcewicz I, Wan-Chow-Wah D, Pumain R, et al. GABA(B) receptor activation promotes seizure activity in the juvenile rat hippocampus. J Neurophysiol. 1999;82:638–47.
Article CAS PubMed Google Scholar
Mares P, Tabashidze N. Contradictory effects of GABA-B receptor agonists on cortical epileptic afterdischarges in immature rats. Brain Res Bull. 2008;75:173–8.
Article CAS PubMed Google Scholar
Avoli M, Lévesque M. GABAB Receptors: are they missing in action in focal epilepsy research? Curr Neuropharmacol. 2022;20:1704–16.
Article CAS PubMed PubMed Central Google Scholar
Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98:641–53.
Article CAS PubMed Google Scholar
Chebib M, Johnston GA. The “ABC” of GABA receptors: a brief review. Clin Exp Pharmacol Physiol. 1999;26:937–40.
Article CAS PubMed Google Scholar
Sieghart W, Savić MM. International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans. Pharmacol Rev. 2018;70:836–78.
Olsen RW, Tobin AJ. Molecular biology of GABAA receptors. FASEB J. 1990;4:1469–80.
Article CAS PubMed Google Scholar
Sigel E, Steinmann ME. Structure, function, and modulation of GABA(A) receptors. J Biol Chem. 2012;287:40224–31.
Article CAS PubMed PubMed Central Google Scholar
Castellano D, Shepard RD, Lu W. Looking for novelty in an “old” receptor: recent advances toward our understanding of GABAARs and their implications in receptor pharmacology. Front Neurosci. 2021;14: 616298.
Comments (0)